| scholarly article | Q13442814 |
| P50 | author | Mitsuro Kanda | Q88589123 |
| P2093 | author name string | Daisuke Kobayashi | |
| Yasuhiro Kodera | |||
| Suguru Yamada | |||
| Goro Nakayama | |||
| Michitaka Fujiwara | |||
| Chie Tanaka | |||
| Masamichi Hayashi | |||
| Takashi Miwa | |||
| Masaya Suenaga | |||
| Haruyoshi Tanaka | |||
| Kenta Murotani | |||
| Shinichi Umeda | |||
| Norifumi Hattori | |||
| P2860 | cites work | Recent advances in the molecular diagnostics of gastric cancer | Q26785548 |
| Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
| Synaptotagmin 8 is expressed both as a calcium-insensitive soluble and membrane protein in neurons, neuroendocrine and endocrine cells | Q28585514 | ||
| Prospective Validation of a 21-Gene Expression Assay in Breast Cancer | Q29011698 | ||
| Prognostic relevance of SAMSN1 expression in gastric cancer | Q30008786 | ||
| Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients | Q31112933 | ||
| A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer | Q33555195 | ||
| Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer | Q34402115 | ||
| Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer | Q35605880 | ||
| Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer | Q37046429 | ||
| Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment | Q37666821 | ||
| A novel gene expression-based prognostic scoring system to predict survival in gastric cancer | Q37688244 | ||
| Discovery of biomarkers for gastric cancer: a proteomics approach | Q38002306 | ||
| Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. | Q38097722 | ||
| Management of gastric cancer in Asia: resource-stratified guidelines | Q38157342 | ||
| Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? | Q38184380 | ||
| GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer | Q38717805 | ||
| Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer | Q38755728 | ||
| Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer | Q38763772 | ||
| Function and diagnostic value of Anosmin-1 in gastric cancer progression | Q38844030 | ||
| Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer | Q38930860 | ||
| Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer | Q39008026 | ||
| Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer | Q39365485 | ||
| Is GAPDH a relevant housekeeping gene for normalisation in colorectal cancer experiments? | Q42346264 | ||
| Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy | Q43128688 | ||
| Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer | Q44149269 | ||
| FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer | Q48961576 | ||
| Genetics of gastric cancer. | Q51219045 | ||
| Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer. | Q51671379 | ||
| Proposal of the Coagulation Score as a Predictor for Short-Term and Long-Term Outcomes of Patients with Resectable Gastric Cancer. | Q53033345 | ||
| The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression. | Q53588322 | ||
| Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. | Q53608312 | ||
| The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. | Q55069791 | ||
| Integrated multigene expression panel to prognosticate patients with gastric cancer. | Q55280375 | ||
| Mapping of INS promoter interactions reveals its role in long-range regulation of SYT8 transcription | Q83449447 | ||
| Gastric cancer: basic aspects | Q84899615 | ||
| Gastric cancer | Q89391950 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2463-2471 | |
| P577 | publication date | 2018-05-07 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer | |
| P478 | volume | 7 |
| Q89884949 | Shared genetic susceptibilities for irritable bowel syndrome and depressive disorder in Chinese patients uncovered by pooled whole-exome sequencing | cites work | P2860 |
Search more.